Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $25.15 million. The enterprise value is $19.83 million.

Market Cap	25.15M
Enterprise Value	19.83M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CVKD has 1.88 million shares outstanding. The number of shares has increased by 43.28% in one year.

Current Share Class	1.88M
Shares Outstanding	1.88M
Shares Change (YoY)	+43.28%
Shares Change (QoQ)	+12.46%
Owned by Insiders (%)	30.69%
Owned by Institutions (%)	7.38%
Float	1.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.51
P/TBV Ratio	4.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.32

Current Ratio	4.32
Quick Ratio	4.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -208.59% and return on invested capital (ROIC) is -133.24%.

Return on Equity (ROE)	-208.59%
Return on Assets (ROA)	-109.43%
Return on Invested Capital (ROIC)	-133.24%
Return on Capital Employed (ROCE)	-214.83%
Revenue Per Employee	n/a
Profits Per Employee	-$3.21M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +93.91% in the last 52 weeks. The beta is 1.50, so CVKD's price volatility has been higher than the market average.

Beta (5Y)	1.50
52-Week Price Change	+93.91%
50-Day Moving Average	16.94
200-Day Moving Average	14.46
Relative Strength Index (RSI)	29.91
Average Volume (20 Days)	23,118

Short Selling Information

The latest short interest is 23,345, so 1.24% of the outstanding shares have been sold short.

Short Interest	23,345
Short Previous Month	32,088
Short % of Shares Out	1.24%
Short % of Float	1.79%
Short Ratio (days to cover)	1.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.13M
Pretax Income	-6.24M
Net Income	-12.83M
EBITDA	-13.13M
EBIT	-13.13M
Earnings Per Share (EPS)	-$9.08

Full Income Statement

Balance Sheet

The company has $7.34 million in cash and n/a in debt, giving a net cash position of $7.34 million or $3.90 per share.

Cash & Cash Equivalents	7.34M
Total Debt	n/a
Net Cash	7.34M
Net Cash Per Share	$3.90
Equity (Book Value)	6.11M
Book Value Per Share	3.20
Working Capital	6.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.17 million and capital expenditures -$9,788, giving a free cash flow of -$10.18 million.

Operating Cash Flow	-10.17M
Capital Expenditures	-9,788
Free Cash Flow	-10.18M
FCF Per Share	-$5.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.28%
Shareholder Yield	-43.28%
Earnings Yield	-47.25%
FCF Yield	-37.48%

Analyst Forecast

The average price target for CVKD is $32.00, which is 139.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	139.16%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.54%

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1